PTNT - ETF AI Analysis
Top Page
Corgi IP Licensing & Royalties ETF (PTNT)
PTNT’s rating suggests it is a reasonably solid ETF, supported by strong holdings like Qualcomm, IBM, and Royalty Pharma, which all benefit from robust financial performance, positive earnings calls, and clear growth strategies. However, names like Yum! Brands and ARM introduce some drag due to high leverage, bearish technical trends, and signs of overvaluation. The main risk factor is that several key holdings show cautionary technical signals and rich valuations, which could make the fund more sensitive to market pullbacks.
PTNT vs. SPDR S&P 500 ETF (SPY)
- AUM
- 1.12M
- Region
- Global
- Expense Ratio
- 0.35%
- Beta
- 1.30
- Issuer
- Corgi
- Inception Date
- May 06, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
PTNT Summary
The Corgi IP Licensing & Royalties ETF (PTNT) is a thematic fund that invests in companies that earn money from patents, royalties, and licenses instead of just selling products. It doesn’t track a traditional index, but focuses on the theme of intellectual property and royalty income across sectors like technology, media, and health care. Well-known holdings include McDonald’s and Netflix, which both benefit from strong brands and licensing deals. Someone might invest for growth and diversification, gaining exposure to cash flows from innovation and content. A key risk is that this is a narrow, specialized theme, so the ETF’s price can be more volatile and can go up and down sharply with changes in IP and royalty markets.
How much will it cost me?
This ETF has an annual expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s a bit higher than the cost of a typical low-fee index ETF because this is a specialized, actively managed strategy focused on intellectual property and royalty-related companies.
What would affect this ETF?
This ETF could benefit if global innovation, streaming, and brand licensing continue to grow, since many of its top holdings like technology, media, and consumer brands rely heavily on intellectual property and royalty income. On the downside, changes in interest rates, weaker consumer spending, or new regulations and legal disputes around patents, copyrights, and royalties could hurt the value of these IP-based cash flows and make this niche financials strategy more volatile.
PTNT Top 10 Holdings
PTNT is powered by a mix of IP-heavy tech and royalty plays, with chip designer ARM and software names like Cadence and Synopsys doing much of the heavy lifting despite some recent choppiness in their share prices. Royalty Pharma has been a bright spot, steadily adding biotech royalty income to the mix. On the softer side, consumer names McDonald’s and Yum! Brands have been lagging, while Netflix and IBM look mixed, losing some steam year-to-date. Overall, the fund leans into global technology and media IP, with a clear thematic tilt toward monetizing intangible assets.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MCD | McDonald's | 7.30% | $81.16K | $182.66B | -14.65% | 65Neutral |
 QCOM | Qualcomm | 6.83% | $75.93K | $175.97B | -7.03% | 80Outperform |
 DIS | Walt Disney | 5.29% | $58.88K | $191.56B | -0.80% | 75Outperform |
 IBM | International Business Machines | 5.33% | $59.25K | $243.66B | -16.85% | 79Outperform |
 NFLX | Netflix | 4.97% | $55.30K | $254.92B | -42.99% | 73Outperform |
 CDNS | Cadence Design | 4.99% | $55.48K | $89.97B | -2.44% | 78Outperform |
 ARM | ARM Holdings PLC ADR | 4.96% | $55.20K | $219.16B | 24.49% | 69Neutral |
 RPRX | Royalty Pharma | 4.67% | $51.92K | $38.72B | 81.86% | 79Outperform |
 SNPS | Synopsys | 4.68% | $52.04K | $89.61B | 5.57% | 73Outperform |
 YUM | Yum! Brands | 4.49% | $50.00K | $42.41B | 11.75% | 59Neutral |
PTNT Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PTNT, the sentiment is Negative. The current price of 24.44 is below the 20-day moving average (MA) of 24.46, above the 50-day MA of 24.43, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.05 indicates Negative momentum. The RSI at 49.73 is Neutral, neither overbought nor oversold. The STOCH value of 78.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PTNT.
PTNT Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| PTNT | $24.44 | $26.00(6.40% Upside) | $1.12M | 0.35% | 67Neutral |
 GOP | $42.68 | $52.71(23.49% Upside) | $94.03M | 0.73% | 69Neutral |
 SAGP | $37.23 | $55.15(48.14% Upside) | $79.42M | 0.65% | 68Neutral |
 PRAY | $34.07 | $42.06(23.43% Upside) | $74.61M | 0.68% | 67Neutral |
 CAMX | $35.15 | $41.43(17.85% Upside) | $67.33M | 0.59% | 67Neutral |
 MNVT | $23.77 | $41.71(75.49% Upside) | $67.35M | 0.75% | 58Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| PTNT | Corgi IP Licensing & Royalties ETF | 24.44 | -1.16 | -4.52% | |
| GOP | Unusual Whales Subversive Republican Trading ETF | 42.68 | 6.12 | 16.75% | |
| SAGP | Strategas Global Policy Opportunities ETF | 37.23 | 4.00 | 12.03% | |
| PRAY | FIS Biblically Responsible Risk Managed ETF | 34.07 | 2.80 | 8.96% | |
| CAMX | Cambiar Aggressive Value ETF | 35.15 | 4.59 | 15.00% | |
| MNVT | Moonvest ETF | 23.77 | -0.94 | -3.81% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.